MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis study tests an experimental drug called epcoritamab (GEN3013) in people with several types of B-cell lymphoma that have relapsed (come back) or are refractory (did not respond to prior treatment). The main goals are to find the safest and most effective dose, monitor side ef…
Matched conditions: MCL
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug duo targets tough lymphoma
Disease control OngoingThis early-phase study tests whether combining glofitamab and lenalidomide can help people with mantle cell lymphoma that has returned or not responded to previous treatments, including a BTK inhibitor. About 39 adults will take part. The main goal is to see if the treatment plan…
Matched conditions: MCL
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:41 UTC